(Q44343328)

2 December 2017

Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects (English)

1 reference

2 December 2017

0 references

Yu-Chang Yeh

1

0 references

Wei-Zen Sun

object named as

Wei-Zen Sun

7

0 references

author name string

Tzu-Fu Lin

2

1 reference

2 December 2017

Hung-Chi Chang

3

1 reference

2 December 2017

Wing-Sum Chan

4

1 reference

2 December 2017

Yong-Ping Wang

5

1 reference

2 December 2017

Chen-Jung Lin

6

1 reference

2 December 2017

1 July 2009

1 reference

Journal of the Formosan Medical Association

2 December 2017

1 reference

2 December 2017

108

1 reference

2 December 2017

7

1 reference

2 December 2017

548-553

1 reference

The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Effect of combining ultralow-dose naloxone with morphine in intravenous patient-controlled analgesia: the cut-off ratio of naloxone to morphine for antiemesis after gynecologic surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Nalbuphine is better than naloxone for treatment of side effects after epidural morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Antiemetic and analgesic-sparing effects of diphenhydramine added to morphine intravenous patient-controlled analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Optimal dose of nalbuphine for treatment of intrathecal-morphine induced pruritus after caesarean section

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

Kappa-opioids produce significantly greater analgesia in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960372-7

7 January 2021

10.1016/S0929-6646(09)60372-7

Identifiers

DOI

1 reference

2 December 2017

1 reference